Ipatasertib (GDC-0068) is a selective, ATP-competitive pan-Akt inhibitor that inhibits Akt1 (IC50:5 nM), Akt2 (IC50:18 nM), and Akt3 (IC50:8 nM). Ipatasertib (GDC-0068) can lead to p53-independent PUMA activation by inhibiting Akt, thereby activating FoxO3a and NF-kappaB simultaneously, directly binding to the PUMA promoter, upregulating PUMA transcription and Bax-mediated intrinsic mitochondrial apoptosis.
Molecular Weight:
458
Purity:
98.28%
CAS Number:
[1001264-89-6]
Formula:
C24H32ClN5O2
Target:
Akt|||Apoptosis
T6252
* VAT and and shipping costs not included. Errors and price changes excepted